News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Curidium Medica plc Announces Change of Adviser



1/23/2008 10:18:45 AM

LONDON, UK, 23 January 2008, Curidium Medica plc, (LSE:CUR), the personalized medicine company focused on bringing the right drug to the right patient, announced today the appointment of JMFinn Capital Markets as nominated adviser and broker, with immediate effect.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES